The goal of this project is to identify the genes (and their respective sequence variants) that play a role in conferring susceptibility to obesity in humans. Knowledge of the nature of these genes, and of the biological mechanism(s) of their actions, would contribute enormously to diagnosis, treatment and prevention of obesity and its allied disorders such as diabetes, cardiovascular disease and certain cancers. 1.) Novel candidate genes influencing adiposity and energy homeostasis will be identified by ongoing surveillance of the literature and by studying large-scale differential gene expression in rodent and human models of altered energy expenditure using cDNA expression microarrays. 2.) Highly sensitive techniques for detecting DNA variants in both coding and predicted regulatory sequences for these candidate genes will be applied to a collection of 2,000 subjects selected for extreme and/or early onset obesity. Allele frequencies of these DNA variants will be determined in four major ethnic groups. Based upon these analyses, phenotypically well-characterized subjects of suitable ethnicity will be selected for association studies from over 88,000 individuals available through 28 collaborating investigators around the world. Statistical analysis will include joint tests of linkage and association using transmission disequilibrium testing, new methods of genomic control, and haplotype analysis. We are also developing new methods to analyze pooled data from multiple populations and to model multiple loci with epistatic interactions. 3.) For variants with positive association results, assessments of possible functional significance will be made using computer modeling and predictions of function, as well as in vitro and in vivo (transgenic) functional assays. In cases in which the alleles associated with increased adiposity have no apparent functional consequence, the entire intronic, exonic, and 5' and 3' regions of the gene will be sequenced in 20 (15 obese; 5 lean) selected subjects to find non-coding variants that account for the phenotypic variation. Coding and non coding sequence variations will be examined for functional effects using in vitro expression techniques and transgenic mice with graded/inducible expression and human allele substitution. Finally, technologies will be developed to rapidly and inexpensively genotype large numbers of subjects for a panel of obesity candidate gene SNPs. Twenty five new genes will be studied over a 5 year period. A great strength of the proposed approach is access to large numbers of phenotypically well characterized subjects of varying ethnicity. These numbers will likely be required to detect sequence variants with specific effects on particular subphenotypes, small phenotypic effects, ethnically-specifc genotypes or epistatic interactions among genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK052431-15S1
Application #
7546037
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Karp, Robert W
Project Start
1996-07-15
Project End
2008-11-30
Budget Start
2007-07-01
Budget End
2008-11-30
Support Year
15
Fiscal Year
2008
Total Cost
$80,500
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Stratigopoulos, George; De Rosa, Maria Caterina; LeDuc, Charles A et al. (2018) DMSO increases efficiency of genome editing at two non-coding loci. PLoS One 13:e0198637
Wang, Liheng; Sui, Lina; Panigrahi, Sunil K et al. (2017) PC1/3 Deficiency Impacts Pro-opiomelanocortin Processing in Human Embryonic Stem Cell-Derived Hypothalamic Neurons. Stem Cell Reports 8:264-277
Schwartz, Michael W; Seeley, Randy J; Zeltser, Lori M et al. (2017) Obesity Pathogenesis: An Endocrine Society Scientific Statement. Endocr Rev 38:267-296
Burnett, Lisa C; LeDuc, Charles A; Sulsona, Carlos R et al. (2017) Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. J Clin Invest 127:293-305
Burnett, Lisa Cole; Hubner, Gabriela; LeDuc, Charles A et al. (2017) Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes. Hum Mol Genet 26:4606-4616
Morabito, Michael V; Ravussin, Yann; Mueller, Bridget R et al. (2017) Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain. PLoS One 12:e0168226
Mosialou, Ioanna; Shikhel, Steven; Liu, Jian-Min et al. (2017) MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543:385-390
Burnett, L C; Skowronski, A A; Rausch, R et al. (2017) Determination of the half-life of circulating leptin in the mouse. Int J Obes (Lond) 41:355-359
Kilpeläinen, Tuomas O; Carli, Jayne F Martin; Skowronski, Alicja A et al. (2016) Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun 7:10494
Webster, Emily; Cho, Megan T; Alexander, Nora et al. (2016) De novo PHIP-predicted deleterious variants are associated with developmental delay, intellectual disability, obesity, and dysmorphic features. Cold Spring Harb Mol Case Stud 2:a001172

Showing the most recent 10 out of 105 publications